Tanzania is East Africa's largest country by population, with over 70 million people spread across a territory roughly four times the size of the United Kingdom. The tanzania healthcare system is built on a decentralised public network that runs from national referral hospitals in Dar es Salaam down to village-level dispensaries. For pharmaceutical companies, CROs, and global health organisations assessing the East African market, Tanzania matters because of its scale, its institutional research capacity, and a digital health footprint that is expanding fast.
This profile covers the system's architecture, disease burden, community health workforce, digital infrastructure, and clinical research activity. It is written for decision-makers evaluating Tanzania alongside regional peers such as Kenya, Uganda, and Rwanda.
Tanzania's Healthcare System at a Glance
Tanzania's health sector operates under the Ministry of Health and the President's Office for Regional Administration and Local Government (PO-RALG). The Ministry sets national policy, manages national-level institutions, and oversees regulatory bodies. PO-RALG is responsible for the delivery of primary and secondary healthcare services through local government authorities.
Health spending remains low. Current health expenditure was approximately 3.4 percent of GDP in 2021, and per capita spending sat at around $36 in 2022, according to World Bank data. The Health Sector Strategic Plan V (HSSP V) projected total health system costs rising from 3.7 trillion Tanzanian shillings in 2021 to 6 trillion shillings by 2025 (roughly $1.6 billion to $2.6 billion).
Health insurance coverage is limited. Only about 15 percent of the population had any form of health insurance as of 2020/21. The National Health Insurance Fund (NHIF) covers roughly 8 percent, the improved Community Health Fund (iCHF) covers about 6 percent, and private schemes account for the rest. The Universal Health Insurance Act of 2023 mandates compulsory health insurance for all Tanzanians, integrating existing schemes under a single pool managed by NHIF. Implementation officially started in January 2026, covering a standard benefits package of 372 health services. HSSP V had targeted 58 percent insurance coverage by 2026, up from 14 percent, though a 2024 mid-term review found progress well below that target. Looking further out, the Tanzania Development Vision 2050, tabled in Parliament in June 2025, sets a life expectancy target of 80 years.
Life expectancy has risen to approximately 67 years as of 2025. Maternal mortality dropped from 556 per 100,000 live births in 2016 to 104 per 100,000 in 2022, an 80 percent reduction driven largely by expanding Emergency Obstetric and Newborn Care (EmONC) centres from 106 in 2014 to 523 in 2023.
Health System Structure: National to Community Level
Healthcare in Tanzania follows a pyramidal referral structure with six tiers. At the base are dispensaries, which serve as the first point of care in villages and wards. Above them sit health centres at the ward level, then district hospitals, regional referral hospitals, zonal referral hospitals, and finally the national referral hospital at the top.
Muhimbili National Hospital (MNH) in Dar es Salaam sits at the top. It is a 1,500-bed teaching hospital affiliated with Muhimbili University of Health and Allied Sciences and takes referral cases from across the country and neighbouring states. A second campus at Mloganzila has expanded the hospital's capacity.
Four zonal referral hospitals in Tanzania anchor specialist care across the country:
- Muhimbili National Hospital for the coastal zone and national referrals
- Kilimanjaro Christian Medical Centre (KCMC) in the northern zone
- Bugando Medical Centre in the western zone (Mwanza)
- Mbeya Zonal Referral Hospital in the southern highlands
Below the zonal level, Tanzania has 62 regional hospitals, split among government facilities, faith-based organisations (FBOs), and private operators. As of 2022/23, there were over 6,000 government-owned primary healthcare facilities across the mainland.
The health workforce is growing but still stretched. HSSP V projected more than 117,000 health service providers by the end of the plan period, up 21 percent from an estimated 97,000 at baseline (HSSP V, Ministry of Health, 2021). Distribution remains skewed toward urban centres, with rural dispensaries often staffed by a single clinical officer or nurse.
Disease Burden and Epidemiological Profile
Tanzania carries a dual burden of communicable and non-communicable diseases. The communicable disease profile is dominated by three conditions:
- Malaria remains the leading cause of death among children and a major contributor to maternal mortality. Tanzania accounts for roughly 3 percent of global malaria cases and 4 percent of global malaria deaths.
- HIV/AIDS prevalence has declined from 7 percent in 2003 to 4.8 percent in 2018, with higher rates in urban areas (7.5 percent) compared to rural areas (4.5 percent). It was the third leading cause of death in 2019.
- Tuberculosis keeps Tanzania on the WHO's high-burden country list. An estimated 154,000 new TB cases were reported in 2017, with 31 percent of those patients also HIV-positive.
Non-communicable diseases are rising as Tanzania undergoes an epidemiological transition. Cancer, ischemic heart disease, and stroke each contribute roughly 3 to 5 percent of total deaths. The government launched a National NCD Control and Prevention Programme, but funding and screening infrastructure remain limited, particularly outside major urban centres.
Under-five and infant mortality rates have declined substantially between 2015 and 2022, driven by vaccination coverage, improved nutrition programmes, and better access to primary care.
Community Health Worker Programme
Tanzania's community health workers do much of the work of extending healthcare beyond the facility walls. In 2024, the government launched the Integrated and Coordinated Community Health Workers Programme, formalising a workforce that had previously operated with inconsistent training and support.
The programme sets clear standards. CHWs must hold a minimum of secondary school education and complete six months of training: three months in the classroom and three months in the field. Earlier models gave community volunteers only brief orientations.
The numbers are large. By 2028, the government aims to deploy 137,294 CHWs across 4,263 urban mitaa and 64,384 rural hamlets. The five-year implementation plan requires an estimated $360 million, with the first year alone costing $40 million. Funding comes from a mix of government budget and development partner support, with Africa CDC among the organisations backing the expansion.
CHWs are now equipped with tablets loaded with the Unified Community System (UCS), enabling them to record patient data digitally and transmit reports in real time. That turns the CHW network into a data collection infrastructure as well as a service delivery channel, generating structured health information from communities that facility-based records typically miss. The Marburg virus outbreak in the Kagera region in early 2025 was an early test of the programme's disease surveillance and rapid response capability.
Platforms like Kapsule that aggregate and structure health facility data across East Africa can complement this community-level data, giving researchers and programme planners a more complete picture of health patterns from facility to village level.
Digital Health and Data Infrastructure
Digital health Tanzania initiatives have accelerated since the publication of the National Digital Health Strategy 2019-2024. The flagship system is GoTHOMIS (Government of Tanzania Health Operation Management Information System), an electronic health management platform introduced by PO-RALG in 2015.
GoTHOMIS handles patient registration, pharmacy management, inpatient and outpatient consultations, and insurance claims processing. As of April 2025, approximately 5,545 healthcare facilities had adopted various versions of GoTHOMIS, covering about 75 percent of all health facilities. Adoption is highest among district hospitals (99 percent), followed by health centres (94 percent) and dispensaries (71 percent).
Implementation has not been without friction. A 2025 assessment identified challenges including inadequate ICT infrastructure, power outages, missing diagnostic codes, and compatibility issues with peripheral devices. A top-down rollout approach with insufficient user input from frontline health workers has complicated adoption in some regions.
Recent partnerships are addressing these gaps. Tanzania and South Korea, through the Korea International Cooperation Agency (KOICA), are collaborating to enhance GoTHOMIS, with a focus on rural connectivity and the integration of AI and telemedicine capabilities. The Dodoma region has been a testbed, with 235 health facilities equipped with upgraded ICT infrastructure.
Tanzania also uses the national DHIS2 (District Health Information Software 2) instance for aggregate health reporting, aligning with the platform used across most of sub-Saharan Africa. Running GoTHOMIS for facility-level operations alongside DHIS2 for national reporting creates interoperability questions that are still being worked out.
Clinical Research Capacity and Trial Activity
Tanzania has serious depth in health research, built around two institutions with decades of track record.
The National Institute for Medical Research (NIMR), established in 1980, has grown from 13 scientists to a network of eight research centres and six research stations distributed across the country according to regional disease burden. NIMR employs approximately 1,000 staff, including 157 research and laboratory scientists, 40 percent of whom hold PhDs. NIMR also serves as the national ethics review body for health research, which matters for any organisation planning clinical trials in the country.
The Ifakara Health Institute (IHI), which marks 70 years of operation in 2026, is a product of long-standing Swiss-Tanzanian collaboration. Its Bagamoyo Research and Training Centre (BRTC) runs Phase II and Phase III malaria vaccine and drug trials to ICH/GCP standards. IHI scientists publish over 100 articles annually in international journals, and the institute maintains laboratory capabilities spanning parasitology, haematology, biochemistry, immunology, molecular biology, and a biosafety level 3 facility.
Clinical trial regulation falls under the Tanzania Medicines and Medical Devices Authority (TMDA). The regulatory pathway is established and well-documented through NIAID's ClinRegs platform. Tanzania trails Kenya and South Africa in total registered trials on ClinicalTrials.gov but holds a growing portfolio, particularly in malaria, TB, HIV, and neglected tropical diseases. A 2025 NIMR-led study evaluating doxycycline and moxidectin for lymphatic filariasis elimination illustrates the kind of disease-specific research that leverages Tanzania's endemic disease profile.
Opportunities for Health Data and Innovation
Tanzania has 70 million people, an expanding digital health infrastructure, and established research institutions. What that means in practice: over 6,000 public primary care facilities generating patient encounters, many now captured digitally through GoTHOMIS. The CHW programme's tablet-based reporting is building a structured dataset from rural and peri-urban communities that facility-based records typically miss. NIMR and IHI handle ethics review, laboratory analysis, and clinical trial execution, which reduces setup time for new studies. And as an East African Community member, Tanzania shares disease profiles, cross-border patient flows, and regulatory harmonisation efforts with Kenya, Uganda, and Rwanda.
The constraints are the usual ones: intermittent power and connectivity in rural areas, workforce shortages, fragmented data systems, and low insurance coverage that limits the financial sustainability of public health services. The Universal Health Insurance Act of 2023 signals political will to address the financing gap, but execution will take years.
For organisations conducting clinical trial planning, market assessments, or epidemiological research, Kapsule's structured health data from across East and West Africa provides a way to benchmark Tanzanian health patterns against regional comparators and identify sites, populations, and disease cohorts suited to specific study designs.
Kapsule provides access to structured, de-identified health records from over three million patient encounters across East and West Africa, with standing ethics approvals in Rwanda, Kenya, Uganda, Nigeria, and Ghana. Contact our team to discuss how Tanzanian health data can support your clinical trial planning, market assessment, or public health research.
This article is intended for informational purposes only and does not constitute legal, medical, or regulatory advice. Readers should obtain independent professional counsel for their specific circumstances.